Largest Catalent site will expand cold chain offerings; First phase completed for Avid's CA upgrade
A Philadelphia Catalent site will get an increase in cold-chain packaging capabilities to gear up for any future increases in gene and cell therapies.
The site will be expanded by 20,000 square feet and add an additional seven temperature-controlled processing suites. Those suites can either be in refrigerated or frozen conditions to match the needs of the drugs handled. There will also be more storage space, and the suites are designed for small-scale batches of commercial products.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
